Eswatini vs Mozambique: HIV-positive TB patients on ART (antiretroviral therapy)
Eswatini
99.0%
in 2024
Mozambique
99.0%
in 2024
Eswatini rank
57th
Mozambique rank
57th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Eswatini
- Mozambique
How they compare
Eswatini currently reports 99.0% against 99.0% in Mozambique, a difference of 0.0%.
The two have swapped places 8 times across 19 shared years of data; in 2006 it was Mozambique ahead.
Eswatini ranks 57th and Mozambique ranks 57th of 144 countries.
Across the 3 decades both report, Eswatini averaged higher in 2 and Mozambique in 1.
Head to head by decade
| Decade | Eswatini | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.0% | 32.8% | 10.8% | Mozambique |
| 2010s | 78.2% | 73.6% | 4.6% | Eswatini |
| 2020s | 98.0% | 97.0% | 1.0% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Eswatini or Mozambique?
- Eswatini, at 99.0% against 99.0% in Mozambique as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Eswatini and Mozambique?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Mozambique?
- 19 years are reported by both, from 2006 to 2024.
- How do Eswatini and Mozambique rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Eswatini ranks 57th and Mozambique ranks 57th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.